$91.53
-4.31-4.50%
Last update: 11:38 AM
15 minutes delayed
Axsome Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Axsome Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $-1.12 | $-1.33 | 15.8 % |
Mar 2024 | 2024-05-06 | $-1.00 | $-1.21 | 17.4 % |
Dec 2023 | 2024-02-20 | $-0.73 | $-1.15 | 36.5 % |
Sep 2023 | 2023-11-06 | $-1.32 | $-1.19 | -10.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $87.17M | $86.92M | 0.28 % |
Mar 2024 | 2024-05-06 | $75.00M | $73.47M | 2.08 % |
Dec 2023 | 2024-02-20 | $71.53M | $67.69M | 5.67 % |
Sep 2023 | 2023-11-06 | $57.79M | $55.75M | 3.67 % |
Axsome Therapeutics (AXSM) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $-1.12, which beat the estimate of $-1.33.
The Actual Revenue was $87.2M, which beat the estimate of $86.9M.
Browse earnings estimates, EPS, and revenue on all stocks.